SPEND £100+ GET 20% OFF
FREE NEXT DAY DELIVERY ON £20 SPEND*
Sale!
CJC-1295 with DAC 2mg
CJC-1295 with DAC 2mg - Image 2
CJC-1295 with DAC 2mg - Image 3
CJC-1295 with DAC 2mg - Image 4
CJC-1295 with DAC 2mg - Image 5
CJC-1295 with DAC 2mg - Image 6
CJC-1295 with DAC 2mg - Image 7
  1. CJC-1295 with DAC 2mg
  2. CJC-1295 with DAC 2mg - Image 2
  3. CJC-1295 with DAC 2mg - Image 3
  4. CJC-1295 with DAC 2mg - Image 4
  5. CJC-1295 with DAC 2mg - Image 5
  6. CJC-1295 with DAC 2mg - Image 6
  7. CJC-1295 with DAC 2mg - Image 7

CJC-1295 with DAC 2mg

Original price was: £16.90.Current price is: £15.90.
  • Batch HPLC tested at 99%+ purity.
  • Store frozen long term or in fridge when ready to be used.
  • Sold for research purposes only.
  • Contact us for Wholesale Orders.

 

Download COA here: CJC-1295 with DAC COA.pdf
Please note if you have a different Batch ID please contact us for the latest COA.

Click to Send Email

 

CJC-1295 with DAC

CJC-1295, also known as DAC:GRF (short for drug affinity complex:growth hormone-releasing factor), is a synthetic analogue of growth hormone-releasing hormone (GHRH) (also known as growth hormone-releasing factor (GRF)) and a growth hormone secretagogue (GHS) which was developed by ConjuChem Biotechnologies.[1][2][3] It is a modified form of GHRH (1-29) with improved pharmacokinetics, especially in regard to half-life.[1][2][3][4]

References
  1. Jetté L, Léger R, Thibaudeau K, Benquet C, Robitaille M, Pellerin I, et al. (July 2005). “Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog”. Endocrinology. 146 (7): 3052–8. doi:10.1210/en.2004-1286. PMID 15817669.
  2. Alba M, Fintini D, Sagazio A, Lawrence B, Castaigne JP, Frohman LA, et al. (December 2006). “Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse”. American Journal of Physiology. Endocrinology and Metabolism. 291 (6): E1290-4. doi:10.1152/ajpendo.00201.2006. PMID 16822960.
  3. Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA (March 2006). “Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults”. The Journal of Clinical Endocrinology and Metabolism. 91 (3): 799–805. doi:10.1210/jc.2005-1536. PMID 16352683.
  4. Thorner MO (June 2008). “The discovery of growth hormone-releasing hormone: an update”. Journal of Neuroendocrinology. 20 (6): 653–4. doi:10.1111/j.1365-2826.2008.01740.x. PMID 18601685. S2CID 29788809.

 

Keywords: CJC-1295 with DAC, CJC with DAC, CJC DAC, CJC1295 with DAC, CJC1295, CJC1295 with DAC.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products offered on this website are furnished for in-vitro studies only. In-vitro studies are performed outside of the body. These products are not medicines or drugs and have not been approved to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden.

➡️ Back to Product Catalogue

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping